ALC is developing adjustable presbyopia-correcting lenses that pair advanced optics with post-surgery light adjustment.

Alcon's $200M RxSight partnership aims to recapture IOL market share with adjustable presbyopic lenses. RxSight gets 30% ...

Alcon and RxSight, Inc have announced a non-exclusive collaboration to jointly develop adjustable presbyopia-correcting ...

RxSight (NASDAQ:RXST) reported preliminary second-quarter financial results and provided updates on its product pipeline ...

Alcon and RxSight announced a nonexclusive collaboration to develop a light-adjustable presbyopia-correcting IOL, according ...

Despite near-term headwinds, RxSight has long-term upside from the Alcon royalty partnership, stronger margins and discounted ...

A new Alcon-sponsored survey conducted by Wakefield Research uncovered a gap between parental recognition of the role of ...

Non-exclusive license agreement for the development and commercialization of novel post-operative light adjustable PCIOL technologies; Collaboration aims to combine best-in-class ...

Over the past several months, generative AI (GenAI) in the medical devices industry has moved from experimental to ...

Detailed price information for Spyglass Pharma Inc (SGP-Q) from The Globe and Mail including charting and trades.

Alcon Lighting is committed to making and distributing the highest quality commercial LED lighting in America. Our team envisions and works to realize a future of lighting that is both efficient and ...